Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Kodiak Sciences Inc

(NASDAQ: KOD)
Add to Portfolio
+1.15 (+1.77%)
as of Jan 17, 2020

Profile
Ticker Symbol KOD
Exchange NASDAQ
Contact Information
2631 HANOVER STREET
PALO ALTO, CA USA
P: 650-281-0850
CEO/President Victor Perlroth
Earnings at a Glance
Earnings 09/30/19
-0.33
06/30/19
-0.31
03/31/19
-0.21
12/31/18
0.68
Price Earnings Ratio N/A
EPS Growth -231.66
Most Recent Earnings ($) -0.33
Annual EPS ($) -1.25
Business Summary
Kodiak Sciences Inc. operates as a clinical stage biopharmaceutical company. It specializes in novel therapeutics to treat chronic and retinal diseases. The company's product candidates consists of KSI-301 for wet AMD KSI-301 for diabetic eye disease KSI-501 for DME and Uveitis KSI-201 for treatment resistant wet AMD and KSI-401 for dry AMD which are in clinical stage. Kodiak Sciences Inc. is based in CA United States.
Industry/Sector Medical - Biomedical
Indices Russell 3000
Indices Russell 2000
Top 100 Stocks